Recent progress in synthesis and application of furoxan

16

1 A. Gasco and A. J. Boulton, Furoxans and benzofuroxans, in

Adv. Heterocycl. Chem., eds. A. R. Katritzky and A. J. Boulton,

Academic Press, 1981, vol. 29, pp. 251–340.

2 A. B. Sheremetev, N. N. Makhova and W. Friedrichsen,

Monocyclic furazans and furoxans, in Adv. Heterocycl.

Chem., Academic Press, 2001, vol. 78, pp. 65–188.

3 H. Cerecetto and W. Porcal, Pharmacological properties of

furoxans and benzofuroxans: recent developments, MiniRev. Med. Chem., 2005, 5, 57–71.

4 A. Kekul´

e, Ueber die Constitution des Knallquecksilbers,

Ann. Chem. Pharm., 1857, 101, 200–213.

5 F. B. Mallory and A. Cammarata, Evidence for the Transient

Existence of 1,2-Dinitrosoalkenes, J. Am. Chem. Soc., 1966,

88, 61–64.

6 M. Calleri, G. Ferraris and D. Viterbo, On the isomerism of

aryl-alkyl-furoxans: The molecular structure of methyl-pbromophenyl-furoxans, Tetrahedron Lett., 1967, 8, 4549–

4551.

7 H. Wieland, Zur Kenntniss der Pseudonitrosite, Justus Liebigs

Ann. Chem., 1903, 329, 225–268.

8 D. L. Hammick, W. A. M. Edwakdes and E. R. Steiner,

CCCCLVIII.—The constitution of benzfurazan and

benzfurazan oxide, J. Chem. Soc., 1931, 3308–3313.

9 F. B. Mallory, S. L. Manatt and C. S. Wood, The rates of some

degenerate rearrangements as determined by nuclear

magnetic resonance spectroscopy, J. Am. Chem. Soc., 1965,

87, 5433–5438.

10 R. Calvino, V. Mortarini, A. Gasco, M. A. Bianco and

M. L. Ricciardi, Furazan and furoxan sulfones - Synthesis

and antimicrobial activity, Eur. J. Med. Chem., 1977, 12,

157–159.

11 H. Cerecetto and M. Gonz´

alez, Benzofuroxan and furoxan.

Chemistry and biology, in Bioactive Heterocycles IV. Topics

© 2023 The Author(s). Published by the Royal Society of Chemistry

17

18

19

20

21

22

23

24

in Heterocyclic Chemistry, ed. M. T. H. Khan, Springer,

Berlin, Heidelberg, 2007, ch. 64, vol. 10, pp. 265–308.

M. Feelisch, K. Schönangeri and H. Noack, Thiol-mediated

generation of nitric oxide accounts for the vasodilator action

of furoxans, Biochem. Pharmacol., 1992, 44, 1149–1157.

C. Medana, G. Ermondi, R. Fruttero, A. Di Stilo, C. Ferretti

and A. Gasco, Furoxans as nitric oxide donors. 4-Phenyl-3furoxancarbonitrile: Thiol-mediated nitric oxide release

and biological evaluation, J. Med. Chem., 1994, 37, 4412–

4416.

G. Rai, A. A. Sayed, W. A. Lea, H. F. Luecke, H. Chakrapani,

S. Prast-Nielsen, A. Jadhav, W. Leister, M. Shen, J. Inglese,

C. P. Austin, L. Keefer, E. S. J. Arn´

er, A. Simeonov,

D. J. Maloney, D. L. Williams and C. J. Thomas, Structuremechanism insights and the role of nitric oxide donation

guide the development of oxadiazole-2-oxides as

therapeutic agents against schistosomiasis, J. Med. Chem.,

2009, 52, 6474–6483.

O. N. Burov, M. E. Kletskii, N. S. Fedik, A. V. Lisovin and

S. V. Kurbatov, Mechanism of thiol-induced nitrogen(II)

oxide donation by furoxans: a quantum-chemical study,

Chem. Heterocycl. Compd., 2015, 51, 951–960.

A. J. Boulton, P. B. Ghosh and A. R. Katritzky, N-oxides and

related compounds. Part XXVIII. 5-Amino- and 5-hydroxybenzofuroxans, J. Chem. Soc. C, 1966, 971–976.

R. D. McCulla, G. Burdzinski and M. S. Platz, Ultrafast study

of the photochemistry of 2-azidonitrobenzene, Org. Lett.,

2006, 8, 1637–1640.

V. Armani, C. Dell'Erba, N. Marino, G. Petrillo and C. Tavani,

Synthetic exploitation of the ring-opening of 3,4dinitrothiophene. Part 7. Access to disubstituted 1,2,5oxadiazole-2-oxides and 2-phenyl-2H-1,2,3-triazole-1-oxides,

Tetrahedron, 1997, 53, 1751–1758.

O. R. Klyuchnikov, V. I. Starovoitov, F. G. Khairutdinov and

V. V. Golovin, Synthesis of condensed nitrofuroxanes using

hydroxylamine, Russ. J. Appl. Chem., 2004, 77, 853–854.

A. G. Green and F. M. Rowe, LV.—The conversion of onitroamines into isooxadiazole oxides, and of onitrosoamines into isooxadiazoles, J. Chem. Soc., Trans.,

1917, 111, 612–620.

D. Britton, W. E. Noland, M. J. Pinnow and V. G. Young Jr.,

Crystal Packing: An examination of the packing of

molecules

approximately

isosteric

with

4,5dichlorophthalic anhydride, Helv. Chim. Acta, 2003, 86,

1175–1192.

E. Del Grosso, D. Boschi, L. Lazzarato, C. Cena, A. Di Stilo,

R. Fruttero, S. Moro and A. Gasco, The furoxan system:

design of selective nitric oxide (NO) donor inhibitors of

COX-2 endowed with anti-aggregatory and vasodilating

activities, Chem. Biodivers., 2005, 2, 886–900.

L. L. Fershtat and F. E. Teslenko, Five-membered hetarene Noxides: recent advances in synthesis and reactivity, Synthesis,

2021, 53, 3673–3682.

L. L. Fershtat and N. N. Makhova, 1,2,5-Oxadiazole-based

high-energy-density materials: synthesis and performance,

ChemPlusChem, 2020, 85, 13–42.

RSC Adv., 2023, 13, 5228–5248 | 5245

View Article Online

Open Access Article. Published on 09 February 2023. Downloaded on 3/7/2023 6:12:17 AM.

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

RSC Advances

25 L. L. Fershtat, M. I. Struchkova, A. S. Goloveshkin,

I. S. Bushmarinov and N. N. Makhova, Dinitrogen trioxide–

mediated domino process for the regioselective

construction of 4-nitrofuroxans from acrylic acids,

Heteroat. Chem., 2014, 25, 226–237.

26 W. V. Farrar, The 3,4-bisarenesulphonylfuroxans, J. Chem.

Soc., 1964, 904–906.

27 G. Sorba, C. Medana, R. Fruttero, C. Cena, A. Di Stilo, U. Galli

and A. Gasco, Water soluble furoxan derivatives as NO

prodrugs, J. Med. Chem., 1997, 40, 463–469.

28 T. I. Godovikova, O. A. Rakitin, S. P. Golova, S. A. Vozchikova

and L. I. Khmel’nitskii, 3,4-Dinitrofuroxan—the rst

example of a pernitro heterocycle, Mendeleev Commun.,

1993, 3, 209–210.

29 R. Fruttero, G. Sorba, G. Ermondi, M. Lolli and A. Gasco,

Unsymmetrically substituted furoxans. Part 17. Structural

investigations in benzenesulfonylfuroxan derivatives and

related compounds, Farmaco, 1997, 52, 405–410.

30 T. I. Godovikova, O. A. Rakitin, S. P. Golova, S. A. Vozchikova,

M. V. Povorin and L. I. Khmel'nitskii, Synthesis and

nucleophilic substitution reactions of 3,4-dinitrofuroxan,

Chem. Heterocycl. Compd., 1994, 30, 465–469.

31 R. Calvino, A. Gasco, A. Serano and D. Viterbo,

Unsymmetrically substituted furoxans. Part 6. 3-Nitro-4phenylfuroxan: reaction with sodium methoxide and X-ray

structural analysis, J. Chem. Soc., Perkin Trans., 1981, 2,

1240–1242.

32 G. Ponzio, Ricerche sulle diossime-LXXXIII, Gazz. Chim. Ital.,

1932, 62, 127–131.

33 R. Matsubara, A. Ando, H. Hasebe, H. Kim, T. Tsuneda and

M. Hayashi, Synthesis and synthetic application of chloroand bromofuroxans, J. Org. Chem., 2020, 85, 5959–5972.

34 L. L. Fershtat, M. A. Epishina, A. S. Kulikov, M. I. Struchkova

and N. N. Makhova, Synthesis of hetarylsulfanyl- and

hetaryloxyfuroxans by nucleophilic substitution of nitro

group in nitrofuroxans with heterocyclic thiol and hydroxy

derivatives, Chem. Heterocycl. Compd., 2015, 51, 176–186.

35 H. Wieland, Ueber Additionsreactionen mit nitrosen Gasen,

Justus Liebigs Ann. Chem., 1903, 328, 154–255.

36 H. Takayama, S. Shirakawa, M. Kitajima, N. Aimi,

K. Yamaguchi, Y. Hanasaki, T. Ide, K. Katsuura,

M. Fujiwara, K. Ijichi, K. Konno, S. Sigeta, T. Yokota and

M. Baba, Utilization of Wieland furoxan synthesis for

preparation of 4-aryl-1,2,5-oxadiazole-3-yl carbamate

derivatives having potent anti-HIV activity, Bioorg. Med.

Chem. Lett., 1996, 6, 1993–1996.

37 L. L. Fershtat, M. A. Epishina, I. V. Ovchinnikov,

M. I. Struchkova, A. A. Romanova, I. V. Ananyev and

N. N. Makhova, Side-chain prototropic tautomerism of 4hydroxyfuroxans in methylation reactions, Tetrahedron

Lett., 2016, 57, 5685–5689.

38 R. Matsubara, Y. Katsuragi, T. Sakaguchi, S. Eguchi,

M. Hayashi and A. Ando, Synthesis of sulfonyloxy furoxans

via hydroxyfuroxan ammonium salts, Tetrahedron, 2018,

74, 3642–3651.

39 G. Sorba, G. Ermondi, R. Fruttero, U. Galli and A. Gasco,

Unsymmetrically substituted furoxans. Part 16. Reaction of

5246 | RSC Adv., 2023, 13, 5228–5248

Review

40

41

42

43

44

45

46

47

48

49

50

51

52

benzenesulfonyl substituted furoxans with ethanol and

ethanethiol in basic medium, J. Heterocycl. Chem., 1996,

33, 327–334.

R. Calvino, A. Gasco, E. Menziani and A. Serano,

Unsymmetrically

substituted

furoxans.

VIII.

Chloromethylfuroxans, J. Heterocycl. Chem., 1983, 20, 783–

785.

D. Boschi, G. Sorba, M. Bertinaria, R. Fruttero, R. Calvino

and A. Gasco, Unsymmetrically substituted furoxans. Part

18. Smiles rearrangement in furoxan systems and in

related furazans, J. Chem. Soc., Perkin Trans., 2001, 1, 1751–

1757.

R. Fruttero, D. Boschi, A. Di Stilo and A. Gasco, The Furoxan

system as a useful tool for balancing "hybrids" with mixed

a1-antagonist and NO-like vasodilator activities, J. Med.

Chem., 1995, 38, 4944–4949.

L. L. Fershtat, M. A. Epishina, A. S. Kulikov and

N. N. Makhova, Design of hetarylthiofuroxans by

nucleophilic substitution of NO2 group in nitrofuroxans,

Mendeleev Commun., 2015, 25, 36–38.

L. L. Fershtat, D. M. Bystrov, E. S. Zhilin and N. N. Makhova,

NOxide-controlled

chemoselective

reduction

of

nitrofuroxans, Synthesis, 2019, 51, 747–756.

¨ ber die einwirkung der halogene auf

H. Wieland, U

knallquecksilber, Ber. Dtsch. Chem. Ges., 1909, 42, 4192–

4199.

Y. Q. Huang, M. M. Liu, L. F. Meng, P. Feng, Y. L. Guo,

M. H. Ying, X. Y. Zhu and Y. Chen, Synthesis and

antitumor

evaluation

of

novel

hybrids

of

phenylsulfonylfuroxan

and

epiandrosterone/

dehydroepiandrosterone derivatives, Steroids, 2015, 101, 7–

14.

O. G. Vlasova, O. A. Rakitin and L. I. Khmelnitski, A simple

synthesis of the heterocyclic S,S-diphenylsullimines, Org.

Prep. Proced. Int., 1994, 26, 331–335.

A. Gasco, V. Mortarini, G. Ru`

a and A. Serano,

Unsymmetrically

substituted

furoxans.

IIII.

Methylnitrofuroxan: Its structure and behavior toward

nucleophilie substitution, J. Heterocycl. Chem., 1973, 10,

587–590.

O. V. Zavarzina, O. A. Rakitin and L. I. Khmel’nitskii,

Substitution of the nitro group in chloronitrofuroxan by Nand O-trimethylsilyl derivatives, Mendeleev Commun., 1994,

4, 135.

L. L. Fershtat, M. A. Epishina, A. S. Kulikov,

I. V. Ovchinnikov, I. V. Ananyev and N. N. Makhova, An

efficient access to (1H-tetrazol-5-yl)furoxan ammonium

salts via a two-step dehydration/[3+2]-cycloaddition

strategy, Tetrahedron, 2015, 71, 6764–6775.

A. Gasco, V. Mortarini, G. Ru`

a and E. Menziani, Alkyl Nmethylfuroxanylcarbamates. Synthesis and structure. II, J.

Heterocycl. Chem., 1972, 9, 837–841.

I. V. Ovchinnikov, K. A. Lyssenko and N. N. Makhova, An

unexpected transformation of 3,4-bis(isocyanato)furoxan

into 3,3’-bi(1,2,4-oxadiazol-5-one), Mendeleev Commun.,

2009, 19, 144–146.

© 2023 The Author(s). Published by the Royal Society of Chemistry

View Article Online

Open Access Article. Published on 09 February 2023. Downloaded on 3/7/2023 6:12:17 AM.

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

Review

53 N. N. Makhova, A. N. Blinnikov and L. I. Khmel’nitskii, The

Schmidt Rearrangement of methyl furoxanyl ketones and

furoxancarboxylic acids: a new synthetic route to

aminofuroxans, Mendeleev Commun., 1995, 5, 56–58.

54 I. V. Ovchinnikov, A. N. Blinnikov, N. N. Makhova and

L. I. Khmel’nitskii, The Curtius rearrangement of

azidocarbonylfuroxans: Some peculiarities and the

synthesis of aminofuroxans, Mendeleev Commun., 1995, 5,

58–60.

55 E. L. Baryshnikova, A. S. Kulikov, I. V. Ovchinnikov,

V. V. Solomentsev and N. N. Makhova, The base-induced

cascade rearrangement of 4-acetylamino-3-arylazo-1,2,5oxadiazole 2-oxides (furoxans) into 4-acetylamino-2-aryl-5nitro-2H-1,2,3-triazoles, Mendeleev Commun., 2001, 11, 230–

232.

56 R. Matsubara, S. Eguchi, A. Ando and M. Hayashi, Synthesis

of alkynyl furoxans. Rare carbon-carbon bond-forming

reaction on a furoxan ring, Org. Biomol. Chem., 2017, 15,

1965–1969.

57 L. Annaratone, S. Guglielmo and K. Y. Chegaev, Direct

introduction of cyano group on furoxan ring, Mendeleev

Commun., 2017, 27, 565–566.

58 J. M. Anderson and J. K. Kochi, Silver(I)-catalyzed oxidative

decarboxylation of acids by peroxydisulfate. Role of

silver(II), J. Am. Chem. Soc., 1970, 92, 1651–1659.

59 R. Matsubara, H. Kim, T. Sakaguchi, W. B. Xie, X. F. Zhao,

Y. Nagoshi, C. Y. Wang, M. Tateiwa, A. Ando, M. Hayashi,

M. Yamanaka and T. Tsuneda, Modular synthesis of

carbon-substituted furoxans via radical addition pathway.

Useful tool for transformation of aliphatic carboxylic acids

based on "build-and-scrap" strategy, Org. Lett., 2020, 22,

1182–1187.

60 C. Dong, X. Zhao, Y. Katsuragi, H. Kim, M. Hayashi and

R. Matsubara, Furoxan incorporation into C–H bonds

enabling nitrogen-containing functional group installation

into the same, J. Org. Chem., 2021, 86, 15807–15817.

61 C. Dong, M. Hayashi and R. Matsubara, Direct arylation of

furoxan using potassium aryltriuoroborates, Heterocycles,

2022, 104, 1770–1781.

62 W. Xie, M. Hayashi and R. Matsubara, Borylfuroxans:

synthesis and applications, Org. Lett., 2021, 23, 4317–4321.

´. Derat, L. Fensterbank,

63 S.-H. Ueng, M. Makhlouf Brahmi, E

E. Lacˆ

ote, M. Malacria and D. P. Curran, Complexes of

borane and N-heterocyclic carbenes: A new class of radical

hydrogen atom donor, J. Am. Chem. Soc., 2008, 130, 10082–

10083.

64 S.-H. Ueng, A. Solovyev, X. Yuan, S. J. Geib, L. Fensterbank,

E. Lacˆ

ote, M. Malacria, M. Newcomb, J. C. Walton and

D. P. Curran, N-Heterocyclic carbene boryl radicals: A new

class of boron-centered radical, J. Am. Chem. Soc., 2009,

131, 11256–11262.

65 A. Ando, R. Matsubara, S. Takazawa, T. Shimada and

M. Hayashi, Fluorofuroxans: Synthesis and application as

photoinduced nitric oxide donors, Asian J. Org. Chem.,

2016, 5, 886–890.

66 M. Decker, Hybrid molecules incorporating natural

products:

Applications

in

cancer

therapy,

© 2023 The Author(s). Published by the Royal Society of Chemistry

RSC Advances

67

68

69

70

71

72

73

74

75

76

77

78

79

neurodegenerative disorders and beyond, Curr. Med.

Chem., 2011, 18, 1464–1475.

Z. Bai, C. Yao, J. Zhu, Y. Xie, X.-Y. Ye, R. Bai and T. Xie, Antitumor drug discovery based on natural product b-elemene:

Anti-tumor mechanisms and structural modication,

Molecules, 2021, 26, 1499.

J. Chen, T. Wang, S. Xu, P. Zhang, A. Lin, L. Wu, H. Yao,

W. Xie, Z. Zhu and J. Xu, Discovery of novel antitumor

nitric oxide-donating b-elemene hybrids through inhibiting

the PI3K/Akt pathway, Eur. J. Med. Chem., 2017, 135, 414–

423.

R. Bai, J. Zhu, Z. Bai, Q. Mao, Y. Zhang, Z. Hui, X. Luo,

X.-Y. Ye and T. Xie, Second generation b-elemene nitric

oxide derivatives with reasonable linkers: potential hybrids

against malignant brain glioma, J. Enzyme Inhib. Med.

Chem., 2022, 37, 379–385.

X. Huang, Y.-S. Wang, D. Ma, Y.-Y. Wang, S.-D. Bian,

B. Zhang, Y. Qiao, Z.-R. He, M. Lv, G.-L. Cai, Z.-X. Wang,

X.-S. Liu, J.-B. Shi and M.-M. Liu, Synthesis and biological

evaluation of novel hybrids of phenylsulfonyl furoxan and

phenstatin derivatives as potent anti-tumor agents, Eur. J.

Med. Chem., 2022, 230, 114112.

W. Fan, P. Huang and X. Chen, Overcoming the Achilles'

heel of photodynamic therapy, Chem. Soc. Rev., 2016, 45,

6488–6519.

X. Guo, H. Yu, W. Shen, R. Cai, Y. Li, G. Li, W. Zhao and

S. Wang, Synthesis and biological evaluation of NO-donor

containing photosensitizers to induce ferroptosis of cancer

cells, Bioorg. Chem., 2021, 116, 105355.

X. Huang, K. Cheng, L. Liu, X. Hu, X. Gao, H. Li, F. Xu, Z. Li,

H. Hua and D. Li, Design, synthesis and apoptosis-related

antiproliferative activities of chelidonine derivatives,

Bioorg. Med. Chem. Lett., 2020, 30, 126913.

Q. Wan, Y. Deng, Y. Huang, Z. Yu, C. Wang, K. Wang, J. Dong

and Y. Chen, Synthesis and antitumor evaluation of novel

hybrids of phenylsulfonylfuroxan and estradiol derivatives,

ChemistryOpen, 2020, 9, 176–182.

Z. Zhang, Z.-W. Bai, Y. Ling, L.-Q. He, P. Huang, H.-X. Gu and

R.-F. Hu, Design, synthesis and biological evaluation of

novel furoxan-based coumarin derivatives as antitumor

agents, Med. Chem. Res., 2018, 27, 1198–1205.

X. Gu, Z. Huang, Z. Ren, X. Tang, R. Xue, X. Luo, S. Peng,

H. Peng, B. Lu, J. Tian and Y. Zhang, Potent inhibition of

nitric oxide-releasing bifendate derivatives against drugresistant K562/A02 cells in vitro and in vivo, J. Med. Chem.,

2017, 60, 928–940.

F. P´

erez, M. Varela, L. Canclini, S. Acosta, W. Mart´ınezL´

opez, G. V. L´

opez and P. Hern´

andez, Furoxans and

tocopherol analogs–furoxan hybrids as anticancer agents,

Anticancer Drugs, 2019, 30, 330–338.

F. Sodano, E. Gazzano, B. Rolando, E. Marini, L. Lazzarato,

R. Fruttero, C. Riganti and A. Gasco, Tuning NO release of

organelle-targeted furoxan derivatives and their cytotoxicity

against lung cancer cells, Bioorg. Chem., 2021, 111, 104911.

X. Hu, X. Gao, G. Gao, Y. Wang, H. Cao, D. Li and H. Hua,

Discovery of b-carboline-(phenylsulfonyl)furoxan hybrids as

RSC Adv., 2023, 13, 5228–5248 | 5247

View Article Online

Open Access Article. Published on 09 February 2023. Downloaded on 3/7/2023 6:12:17 AM.

This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence.

RSC Advances

potential anti-breast cancer agents, Bioorg. Med. Chem. Lett.,

2021, 40, 127952.

80 N. Yu, N. Li, K. Wang, Q. Deng, Z. Lei, J. Sun and L. Chen,

Design, synthesis and biological activity evaluation of

novel scopoletin-NO donor derivatives against MCF-7

human breast cancer in vitro and in vivo, Eur. J. Med.

Chem., 2021, 224, 113701.

81 L. A. Dutra, L. d. Almeida, T. G. Passalacqua, J. S. Reis,

F. A. E. Torres, I. Martinez, R. G. Peccinini, C. M. Chin,

K. Chegaev, S. Guglielmo, R. Fruttero, M. A. S. Graminha

and J. L. d. Santos, Leishmanicidal activities of novel

synthetic

furoxan

and

benzofuroxan

derivatives,

Antimicrob. Agents Chemother., 2014, 58, 4837–4847.

82 L. d. C. Clementino, G. F. S. Fernandes, I. M. Prokopczyk,

W. C. Laurindo, D. Toyama, B. P. Motta, A. M. Baviera,

F. Henrique-Silva, J. L. d. Santos and M. A. S. Graminha,

Design, synthesis and biological evaluation of N-oxide

derivatives with potent in vivo antileishmanial activity,

PLoS One, 2021, 16, e0259008.

5248 | RSC Adv., 2023, 13, 5228–5248

Review

83 Y. Hotta, T. Kataoka, T. Mori and K. Kimura, Review of

a potential novel approach for erectile dysfunction: Lightcontrollable nitric oxide donors and nanoformulations,

Sex. Med. Rev., 2020, 8, 297–302.

84 S. Sortino, Light-controlled nitric oxide delivering molecular

assemblies, Chem. Soc. Rev., 2010, 39, 2903–2913.

85 R. Matsubara, S. Takazawa, A. Ando, M. Hayashi, R. Tohda

and M. Tsubaki, Study on the photoinduced nitric-oxidereleasing ability of 4-alkoxy furoxans, Asian J. Org. Chem.,

2017, 6, 619–626.

86 C. P. Seymour, R. Tohda, M. Tsubaki, M. Hayashi and

R. Matsubara, Photosensitization of uorofuroxans and its

application to the development of visible light-triggered

nitric oxide donor, J. Org. Chem., 2017, 82, 9647–9654.

87 C. P. Seymour, A. Nakata, M. Tsubaki, M. Hayashi and

R. Matsubara, A uorescent naphthalenediimidealkoxyfuroxan photoinduced nitric oxide donor, Bull.

Chem. Soc. Jpn., 2019, 92, 162–169.

© 2023 The Author(s). Published by the Royal Society of Chemistry

...